Midgut Neuroendocrine Tumor — Trials

Midgut Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

6 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–6 of 6 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01841736	Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors	active not recruiting	Phase 2	171	National Cancer Institute (NCI)NIH	2	Aug 28, 2026	clinicaltrials
NCT03891784	Abemaciclib in Treating Patients With Advanced, Refractory, and Unresectable Digestive System Neuroendocrine Tumors	active not recruiting	Phase 2	20	University of WashingtonOTHER	1	Jan 14, 2026	clinicaltrials
NCT04735198	Prophylactic Cholecystectomy in Midgut NETs Patients Who Require Primary Tumor Surgery.(TNE-IDC-COLE)	recruiting	N/A	100	Hospital Universitari de BellvitgeOTHER	1	May 20, 2025	clinicaltrials
NCT03667092	Exploration of Molecular Biomarkers for Lu-177 DOTATATE Therapy in Midgut Neuroendocrine Tumor(GENEBIOLuNET)	completed	N/A

Data updated 22 days agoSource updated Aug 28, 2026source: clinicaltrials